CCL2 is a key molecule mediating GAM recruitment in human glioma37 and expression is negatively associated with median survival time in human glioma patients.38 Similarly, CCL2 was highly expressed in high-grade canine astrocytoma and likely plays a critical role in GAM recruitment in canine tumors. Here, CCL2 is linked to central nervous system cancer.